Financials
Financial year 2024
PHARMACIE DEMEL from Beloeil, company number BE0475363148, closed financial year 2024 with a result of € 153,807 after tax. For that financial year PHARMACIE DEMEL recorded a gross margin of € 420,443 and equity of € 474,996. Compared with financial year 2023, the result moved from € 101,306 to € 153,807. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2025.
€ 474,996
▲ 36% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 153,807
▲ 52% vs 2023
Profit after tax over the fiscal year.
€ 309,895
▲ 185% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 29,000 paid out
19 % of the profit went to the shareholders, mostly to PIALOR SPRL (100 % of the shares). That is where the money ends up.
People and assets in 2024
2.7
▼ 0.1 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 131,021
▲ 14% vs 2023
€ 48,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,701
▼ 19% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 7,500
Loans from banks and other lenders, long and short.
€ 159,083
▼ 4% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 47,206
▼ 13% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 306,991 | € 437,229 | € 359,883 | € 420,443 | ▲ 17% |
| Profit after taxes | € 91,203 | € 167,386 | € 101,306 | € 153,807 | ▲ 52% |
| Equity | € 191,696 | € 299,483 | € 350,189 | € 474,996 | ▲ 36% |
| Total debts | € 272,949 | € 322,375 | € 340,522 | € 312,280 | ▼ 8% |
| Cash | € 148,187 | € 142,807 | € 108,605 | € 309,895 | ▲ 185% |
| Retained profit | € 173,096 | € 280,883 | € 331,589 | € 456,396 | ▲ 38% |
| Dividend | € 130,220 | € 59,600 | € 50,600 | € 29,000 | ▼ 43% |
| Bank debt | € 0 | € 0 | € 7,500 | € 7,500 | |
| Balance sheet total | € 464,645 | € 621,858 | € 690,711 | € 787,276 | ▲ 14% |
| Employees (FTE) | 2 | 2.2 | 2.8 | 2.7 | ▼ 0.1 |
Key figures of PHARMACIE DEMEL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMACIE DEMEL?
What happened at PHARMACIE DEMEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 153,807 (▲ 52% vs 2023). Source: NBB ↗
- New establishment in Beloeil. KBO
- Start of the company according to the CBE. KBO
In short
From € 91,203 profit in 2021 to € 153,807 profit in 2024.
Paid € 201,963 in corporate taxes since 2021.
Best year ever: 2022, with € 167,386 profit.
On average € 155,700 of value added per employee in 2024.
A new publication or filing at PHARMACIE DEMEL? We notify you, reason included.
Follow PHARMACIE DEMELDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PIALOR SPRL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DEMELBehind PHARMACIE DEMEL is Michaël PIACENTINI. The shares are held by PIALOR SPRL (100%).
Directors
According to the 2024 annual accounts
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue du Château (Bel) 19
7970 Beloeil
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0475.363.148
- VAT number
- BE 0475.363.148
- Registered office
- Rue du Château (Bel) 19, 7970 Beloeil
- Names & denominations
- PHARMACIE DEMEL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 July 2001
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers